Invesco NASDAQ Biotech UCITS ETF | SBIORegister to Unlock Ratings |
Performance History | 29/02/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | 23.4 | 0.4 | -0.8 | 0.2 | 1.8 | |
+/-Cat | -2.5 | 9.5 | 7.1 | 1.4 | -2.4 | |
+/-B’mrk | -9.5 | 0.1 | -3.2 | -7.2 | -3.2 | |
Category: Sector Equity Biotechnology | ||||||
Category Benchmark: Morningstar Gbl Biotechnolo... |
Key Stats | ||
Closing Price 31/03/2024 | USD 46.01 | |
Day Change | - | |
Morningstar Category™ | Sector Equity Biotechnology | |
Volume | 39736 | |
Exchange | LONDON STOCK EXCHANGE, THE | |
ISIN | IE00BQ70R696 | |
Fund Size (Mil) 27/03/2024 | USD 644.55 | |
Share Class Size (Mil) 27/03/2024 | USD 644.55 | |
Ongoing Charge 22/08/2023 | 0.40% |
Investment Objective: Invesco NASDAQ Biotech UCITS ETF | SBIO |
The investment objective of the Fund is to achieve the total return performance of the NASDAQ Biotechnology Index (the "Reference Index") less fees, expenses and transaction costs. The Reference Index is designed to represent the performance of biotechnology and pharmaceutical securities on the NASDAQ Stock Market®. |
Returns | |||||||||||||
|
Management | ||
Manager Name Start Date | ||
- - | ||
Inception Date 06/11/2014 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
NASDAQ Biotechnology TR USD | Morningstar Gbl Biotechnology NR USD |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for Invesco NASDAQ Biotech UCITS ETF | SBIO | 29/02/2024 |
|
|
Top 5 Holdings | Sector | % |
TRS NASDAQ Biotechnology TR USD | 100.00 | |
Increase Decrease New since last portfolio | ||
Invesco NASDAQ Biotech UCITS ETF | SBIO |